Clinical Trial Update: Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of nimotuzumab plus irinotecan in metastatic colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: YM BioSciences | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED